Medco IPO Will Value Company At $5.9-$6.5 Bil. – Amended Prospectus

Merck's amended IPO prospectus for Medco Health Solutions suggests that the spin-off will be valued at just below the price that Merck paid for the business in 1993

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet